Literature DB >> 23801865

Role of international criteria in the diagnosis of autoimmune hepatitis.

Mohammad Reza Abdollahi1, Mohammad Hossein Somi, Esmaeil Faraji.   

Abstract

AIM: To study the clinical and laboratory characteristics of autoimmune hepatitis (AIH), and compare them with International Autoimmune Hepatitis Group (IAHG) criteria.
METHODS: Sixty consecutive patients with AIH attended the University Clinic at Tabriz University of Medical Sciences, Iran for a 12 mo period and were assessed in a case series study. Serological and biochemical evaluations were carried out in all patients. Autoantibodies, such as antinuclear antibody (ANA), anti-smooth muscle antibody (ASMA), anti-liver-kidney microsomal antibody (ALKM-1) type 1, and perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) were evaluated in these patients. A liver biopsy was performed after diagnosis of the disease. Patients were evaluated in terms of their signs and symptoms, and laboratory results and the degree to which they corresponded with the diagnostic criteria of IAHG. In this study, both a comprehensive diagnostic scoring system and a simplified diagnostic scoring system were employed for AIH.
RESULTS: Sixty patients, 20 male, 40 female, mean age 39.45 ± 17.50 years, participated in the study. Treatment began immediately after enrolment into the study. The percent distribution of the study population into definite and probable did not change after the treatment. The most common symptoms in descending order were fatigue (100%), icter (66.7%), abdominal discomfort (33.3%), abdominal distension (28.3%), dark urine (23.3%), edema (23.3%), hematemesis (20.0%), pruritus (20.0%), melena (11.7%) and pale stool (10.0%). At the physical examination, splenomegaly, ascites, hepatomegaly, epigastric tenderness and an abdominal mass were found in 50.0%, 16.7%, 13.3%, 5.0% and 3.3% of patients, respectively. Hypergammaglobulinemia was detected in 95.0% of cases. ALKM-1, P-ANCA, ANA and ASMA were positive in 71.4%, 66.7%, 42.4% and 19.4% of cases, respectively. Portal hypertensive gastropathy (45.0%), esophageal varices (41.7%) and cirrhosis (40.0%) were the most prevalent complications of AIH, and there was no evidence of primary sclerosing cholangitis, ulcerative colitis and overlap syndrome in these patients. According to IAHG criteria, 80.0% of cases had a definite diagnosis, 15.0% had a probable diagnosis and 5.0% had no AIH. The percent distribution of the study population into definite, probable and no AIH did not change after using the simplified diagnostic scoring system for AIH.
CONCLUSION: This research showed that the majority of cases in our study were appropriately diagnosed according to the IAHG criteria and simplified scoring system. Thus, these criteria are very useful.

Entities:  

Keywords:  Autoimmune hepatitis; Clinical; Diagnosis; International criteria; Paraclinical

Mesh:

Substances:

Year:  2013        PMID: 23801865      PMCID: PMC3691026          DOI: 10.3748/wjg.v19.i23.3629

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  [Clinical and pathological characteristics and pathogenesis of autoimmune hepatitis].

Authors:  Jingmin Zhao; Songshan Wang; Yanling Sun; Guangde Zhou; Ping Liu; Erhong Meng; Shaojie Xin; Taihe Zhang; Fusheng Wang; Yuanli Mao; Li Li; Yingxin Li; Hongfei Zhang; Lingxia Zhang; Jumei Chen
Journal:  Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi       Date:  2002-03

2.  Diagnosis and treatment of autoimmune hepatitis.

Authors:  Albert J Czaja; Deborah K Freese
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

3.  Autoimmune hepatitis in the Indian subcontinent: 7 years experience.

Authors:  R Gupta; S R Agarwal; M Jain; V Malhotra; S K Sarin
Journal:  J Gastroenterol Hepatol       Date:  2001-10       Impact factor: 4.029

4.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

Review 5.  Current concepts in the diagnosis, pathogenesis, and treatment of autoimmune hepatitis.

Authors:  J A Al-Khalidi; A J Czaja
Journal:  Mayo Clin Proc       Date:  2001-12       Impact factor: 7.616

6.  [Autoantibodies characteristic for autoimmune hepatitis found in chronic hepatitis C].

Authors:  Slanjana Pavić; Jasmina Simonović; Ivan Boricić; Neda Svirtlih
Journal:  Srp Arh Celok Lek       Date:  2003 Nov-Dec       Impact factor: 0.207

7.  [Incidence and prevalence of autoimmune hepatitis in the area of the Hospital de Sagunto (Spain)].

Authors:  J Primo; C Merino; J Fernández; J R Molés; P Llorca; J Hinojosa
Journal:  Gastroenterol Hepatol       Date:  2004-04       Impact factor: 2.102

8.  Simplified criteria for the diagnosis of autoimmune hepatitis.

Authors:  Elke M Hennes; Mikio Zeniya; Albert J Czaja; Albert Parés; George N Dalekos; Edward L Krawitt; Paulo L Bittencourt; Gilda Porta; Kirsten M Boberg; Harald Hofer; Francesco B Bianchi; Minoru Shibata; Christoph Schramm; Barbara Eisenmann de Torres; Peter R Galle; Ian McFarlane; Hans-Peter Dienes; Ansgar W Lohse
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

9.  The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver disease.

Authors:  Leon A Adams; Keith D Lindor; Paul Angulo
Journal:  Am J Gastroenterol       Date:  2004-07       Impact factor: 10.864

10.  Autoimmune hepatitis in the material of Department and Regional Hospital of Infectious Diseases in Gdańsk.

Authors:  Zofia Michalska; Danuta Radowska; Piotr Staike; Katarzyna Sikorska; Anna Lakomy; Krystyna Witczak-Malinowska; Alicja Bakowska; Julian Stolarczyk; Hanna Trocha; Agnieszka Pawiak; Maciej Kowalik
Journal:  Med Sci Monit       Date:  2003-08
View more
  7 in total

1.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08

Review 2.  Autoimmune hepatitis.

Authors:  Farhad Sahebjam; John M Vierling
Journal:  Front Med       Date:  2015-03-06       Impact factor: 4.592

Review 3.  Auto immune hepatitis.

Authors:  Nicole Mf van Gerven; Ynto S de Boer; Chris Jj Mulder; Carin Mj van Nieuwkerk; Gerd Bouma
Journal:  World J Gastroenterol       Date:  2016-05-21       Impact factor: 5.742

4.  Non-invasive serum fibrosis markers: A study in chronic hepatitis.

Authors:  Mohammadreza Abdollahi; Aliasghar Pouri; Morteza Ghojazadeh; Rasoul Estakhri; Mohammadhossein Somi
Journal:  Bioimpacts       Date:  2015-02-22

5.  Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis.

Authors:  Jin Wang; Neera Malik; Meng Yin; Thomas C Smyrk; Albert J Czaja; Richard L Ehman; Sudhakar K Venkatesh
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

6.  Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations?

Authors:  Mohammadreza Abdollahi; Neda Khalilian Ekrami; Morteza Ghojazadeh; H Marike Boezen; Mohammadhossein Somi; Behrooz Z Alizadeh
Journal:  World J Gastroenterol       Date:  2020-10-14       Impact factor: 5.742

7.  Diagnosis and Treatment of Autoimmune Liver Diseases in a Tertiary Referral Center in Cuba.

Authors:  Marlen Ivón Castellanos Fernández; Deyanira la Rosa Hernández; Diego Enrique Cabrera Eugenio; Wilson Palanca; Zaily Dorta Guridi; Licet González Fabián
Journal:  Curr Ther Res Clin Exp       Date:  2017-04-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.